Eli Lilly's stock price rose 2.2% in pre-market trading.
2025-08-26 19:08:28

Eli Lilly's shares rose 2.2% in premarket trading after its oral GLP-1 drug reduced weight by 10.5% in patients with type 2 diabetes in a late-stage trial.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download